The product has the potential to be non-sterile as it was not packaged in accordance to specification.
Source facts
Action
On January 13, 2017 Navilyst Medical initiated a recall action by contacting the 6 consignees by telephone and directing them to stop using the affected product and segregate until receipt of written Recall Notification. Recall Notifications dated January 19, 2017 were delivered by Federal Express to these consignees on January 20, 2017. Per the Recall Notification, Consignees are instructed to segregate and return all affected devices to Navilyst Medical, Inc. (an AngioDynamics Company) and complete and return the Reply Verification Tracking Form, provided in the recall notification.
Initiated
2017-01-13
Root cause
Under Investigation by firm
Terminated
2018-06-25
Distribution
CA, KY, MD, OR, VA, TX
Recall number
Z-1853-2017
Recall status
Terminated
CDRH record ID
152938
FDA classified
2017-03-29
Recall event number
76347
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.